These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 28642302
1. Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin. Garbowski MW, Evans P, Vlachodimitropoulou E, Hider R, Porter JB. Haematologica; 2017 Oct; 102(10):1640-1649. PubMed ID: 28642302 [Abstract] [Full Text] [Related]
2. Interaction of Transfusion and Iron Chelation in Thalassemias. Porter JB, Garbowski MW. Hematol Oncol Clin North Am; 2018 Apr; 32(2):247-259. PubMed ID: 29458730 [Abstract] [Full Text] [Related]
3. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions. Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT. Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462 [Abstract] [Full Text] [Related]
4. Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice. Gelderman MP, Baek JH, Yalamanoglu A, Puglia M, Vallelian F, Burla B, Vostal J, Schaer DJ, Buehler PW. Haematologica; 2015 May; 100(5):611-22. PubMed ID: 25616571 [Abstract] [Full Text] [Related]
5. Iron and oxidative stress in cardiomyopathy in thalassemia. Berdoukas V, Coates TD, Cabantchik ZI. Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855 [Abstract] [Full Text] [Related]
6. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. de Swart L, Reiniers C, Bagguley T, van Marrewijk C, Bowen D, Hellström-Lindberg E, Tatic A, Symeonidis A, Huls G, Cermak J, van de Loosdrecht AA, Garelius H, Culligan D, Macheta M, Spanoudakis M, Panagiotidis P, Krejci M, Blijlevens N, Langemeijer S, Droste J, Swinkels DW, Smith A, de Witte T, EUMDS Steering Committee. Haematologica; 2018 Jan; 103(1):69-79. PubMed ID: 29122992 [No Abstract] [Full Text] [Related]
7. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E. Br J Haematol; 2014 Dec; 167(5):692-6. PubMed ID: 25209728 [Abstract] [Full Text] [Related]
8. The role of endocytic pathways in cellular uptake of plasma non-transferrin iron. Sohn YS, Ghoti H, Breuer W, Rachmilewitz E, Attar S, Weiss G, Cabantchik ZI. Haematologica; 2012 May; 97(5):670-8. PubMed ID: 22180428 [Abstract] [Full Text] [Related]
9. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia. Huang Y, Lei Y, Liu R, Liu J, Yang G, Xiang Z, Liang Y, Lai Y. Int J Med Sci; 2019 May; 16(2):302-310. PubMed ID: 30745811 [Abstract] [Full Text] [Related]
13. Uptake and release of iron from human transferrin. Huebers H, Josephson B, Huebers E, Csiba E, Finch C. Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2572-6. PubMed ID: 6941310 [Abstract] [Full Text] [Related]
15. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice. Li H, Choesang T, Bao W, Chen H, Feola M, Garcia-Santos D, Li J, Sun S, Follenzi A, Pham P, Liu J, Zhang J, Ponka P, An X, Mohandas N, Fleming RE, Rivella S, Li G, Ginzburg YZ. Blood; 2017 Mar 16; 129(11):1514-1526. PubMed ID: 28151426 [Abstract] [Full Text] [Related]
16. Citrate and albumin facilitate transferrin iron loading in the presence of phosphate. Matias C, Belnap DW, Smith MT, Stewart MG, Torres IF, Gross AJ, Watt RK. J Inorg Biochem; 2017 Mar 16; 168():107-113. PubMed ID: 28110161 [Abstract] [Full Text] [Related]